CTOs on the Move

Concert Pharmaceuticals

www.concertpharma.com

 
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company`s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Funding

Concert Pharmaceuticals raised $30M on 06/12/2017
Concert Pharmaceuticals raised $66.4M on 06/01/2022

Similar Companies

Ameridose

Ameridose is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stason Pharmaceuticals Inc

Stason Pharmaceuticals Inc is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Erfa Canada Inc

Erfa Canada Inc is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Purdue Pharma L.P.

Purdue Pharma LP is a privately held pharmaceutical company founded by John Purdue Gray.

PharMetrics

PharMetrics, Inc. is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.